Cell proliferation index predicts relapse of brain metastases in non-irradiated patients
| Autor: | Dimitar Haritonov, G. N. Chaldakov, A. B. Tonchev, Nikolay Peev, Milena Penkowa, Svetoslav Kalevski |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Oncology
Adult Male medicine.medical_specialty Systemic disease Pathology Neurology Lung Neoplasms medicine.medical_treatment Biopsy CD47 Antigen Neurosurgical Procedures Metastasis Predictive Value of Tests Internal medicine medicine Biomarkers Tumor Mitotic Index Humans Aged Cell Proliferation medicine.diagnostic_test business.industry Brain Neoplasms Carcinoma Interventional radiology Middle Aged medicine.disease Immunohistochemistry Disease Progression Surgery Female Neurology (clinical) Neurosurgery Neoplasm Recurrence Local business Complication Adjuvant Brain metastasis |
| Zdroj: | Acta neurochirurgica. 150(10) |
| ISSN: | 0942-0940 |
| Popis: | Brain metastasis is a common complication and a major cause of morbidity and mortality in human malignancies. We investigated whether the proliferating cell index of surgically treated single brain metastasis would predict the relapse at a location remote from the initial resection site within 2 months of the excision in patients with uncontrolled systemic disease and not subjected to adjuvant whole brain radio-therapy.Tissue biopsies derived from 25 patients with brain metastases specifically selected to be a single totally resected lesion and not treated subsequently by radiotherapy to the whole brain were stained by immunohistochemistry for the marker CDC47 and the proliferation index was calculated. The index was then analysed with respect to clinical parameters, including the incidence of brain relapse within 2 months of the first resection, the timing of diagnosis of brain metastasis as compared to the primary cancer diagnosis, and the perifocal brain oedema.Statistical evaluation of the indexes in the patients with brain metastases relapsing within 2 months after the first craniotomy (n = 13) revealed significantly higher values as compared to the patients with lesions which had not relapsed or which had relapsed more than 2 months after first craniotomy (n = 12). The synchronous brain metastasis (that is, those occurring before or within 2 months of the primary cancer diagnosis) had a significantly higher proliferation index than the metachronous lesions (those occurring more than 2 months after primary cancer diagnosis).The synchronous brain metastasis relapses within 2 months of primary resection and have a significantly higher proliferation index than the metachronous lesions which did not recur within 2 months. These results indicate that the estimation of the proliferation index of metastatic brain tumours may be helpful in predicting the course of disease progression. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink